tiprankstipranks
Regeneron (REGN)
NASDAQ:REGN
US Market
REGN
Regeneron
RESEARCH TOOLSreports
Want to see REGN full AI Analyst Report?

Regeneron (REGN) Stock News & Sentiment

5,187 Followers
Regeneron: Earnings Strength and Pipeline Optionality Support Buy Rating as 12-Month Price Target Ticks Up to $968
Premium
Ratings
Regeneron: Earnings Strength and Pipeline Optionality Support Buy Rating as 12-Month Price Target Ticks Up to $968
3d ago
REGN
Regeneron: Buy Rating Reiterated as Analyst Sees Melanoma Trial Sell-Off Overdone; $900 Price Target Unchanged
Premium
Ratings
Regeneron: Buy Rating Reiterated as Analyst Sees Melanoma Trial Sell-Off Overdone; $900 Price Target Unchanged
4d ago
REGN
Regeneron Earnings Call Highlights Durable Growth Engine
Premium
Company Announcements
Regeneron Earnings Call Highlights Durable Growth Engine
4d ago
REGN
These Are the Stocks Reporting Earnings Today – April 29, 2026
Premium
Market News
These Are the Stocks Reporting Earnings Today – April 29, 2026
5d ago
F
GD
Regeneron Pharmaceuticals (REGN) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Regeneron Pharmaceuticals (REGN) Q1 Earnings Cheat Sheet
7d ago
REGN
Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth
Premium
Company Announcements
Regeneron’s High-Dose Aflibercept Trial in China Nears a Key Inflection Point for Eye-Care Growth
1M ago
REGN
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
Premium
Market News
Get Ready for a $5.7 Trillion ‘Triple-Witching’ Event on Friday
2M ago
DIA
PDD
More REGN News >

REGN News on the Web

Sanofi's Nuvaxovid Shows Superior Tolerability Over Moderna's MNEXSPIKE In COMPARE Study
rttnews
Neutral
3 Catalysts That Could Send Teva Stock to $40 and Beyond
The Motley Fool
Bearish
Is the Telix share price heading to $19? This broker thinks it is
The Motley Fool
Neutral
Trump names Erica Schwartz CDC Director
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), McKesson (MCK) and Regeneron (REGN)
TipRanks News
Neutral
Citizens biotechnology analyst holds analyst/industry conference call
TipRanks News
Neutral
Regeneron Boosts Cancer Pipeline Through Telix Collaboration
Zacks
Bullish
Regeneron Pharmaceuticals (REGN) Partners with Telix for Radiopharmaceutical Development
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
REGN
Sector Average
Media Buzz
This Week7 articles
Weekly Average15 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REGN’s Media Buzz Sentiment?
7 articles about REGN were published this week. In an average week, 15 articles are published.
    What is REGN’s weekly average amount of articles?
    In an average week, 15 articles about REGN are published.
      What is REGN’s News Sentiment?
      50% of articles about REGN were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week